Clinical Trial Update: Phase II Dose Titration Study in Patients With Neuropathic Pain [Phase 2]

View source ↗

Summary

Phase II dose-titration study in patients with neuropathic pain has completed. This update reports the current status of the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Snippet

Sponsor: Newron Pharmaceuticals SPA | Conditions: Neuropathic Pain | Phase 2 | Status: COMPLETED